Insider · CIK 0002087366
Bradley Evan Burnam
Files at TTRX (Turn Therapeutics Inc.). First filing -, latest -.
In brief
Bradley Evan Burnam files SEC Form 4 as CEO, director and 10% owner at TTRX (Turn Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bradley Evan Burnam has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | TTRX Turn Therapeutics Inc. | GGift Common Stockindirect: By BEB Holdings, LLC | -300,000 | $0.00 | $0 | 15,416,260 | Jun 1, 2026 |
| May 28, 2026 | TTRX Turn Therapeutics Inc. | GGift Common Stockindirect: See footnote | +300,000 | $0.00 | $0 | 300,000 | Jun 1, 2026 |
| May 28, 2026 | TTRX Turn Therapeutics Inc. | GGift Common Stockindirect: By BEB Holdings, LLC | -300,000 | $0.00 | $0 | 15,116,260 | Jun 1, 2026 |
| May 28, 2026 | TTRX Turn Therapeutics Inc. | GGift Common Stockindirect: See footnote | +300,000 | $0.00 | $0 | 300,000 | Jun 1, 2026 |
| Apr 2, 2026 | TTRX Turn Therapeutics Inc. | GGift Common Stockindirect: By BEB Holdings, LLC | -300,000 | $0.00 | $0 | 15,716,260 | Apr 3, 2026 |
| Apr 1, 2026 | TTRX Turn Therapeutics Inc. | AGrant or award Employee stock option (right to buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Apr 3, 2026 |
Questions about Bradley Evan Burnam
Answered from the filings on this page, as of the latest one.
Is Bradley Evan Burnam buying or selling?
Bradley Evan Burnam has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bradley Evan Burnam's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bradley Evan Burnam has 0.
Where does Bradley Evan Burnam file Form 4?
Bradley Evan Burnam has filed Form 4 at TTRX (Turn Therapeutics Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.